Parkside Financial Bank & Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
3,990
-7
-0.2% -$2.5K 0.11% 125
2025
Q4
$1.31M Sell
3,997
-5
-0.1% -$1.59K 0.1% 129
2025
Q3
$1.13M Sell
4,002
-59
-1% -$17.1K 0.09% 138
2025
Q2
$1.13M Buy
4,061
+214
+6% +$60.6K 0.12% 134
2025
Q1
$1.2M Buy
3,847
+116
+3% +$34.3K 0.15% 111
2024
Q4
$972K Sell
3,731
-38
-1% -$11.3K 0.13% 125
2024
Q3
$1.21M Buy
3,769
+325
+9% +$106K 0.17% 102
2024
Q2
$1.08M Sell
3,444
-152
-4% -$44.7K 0.17% 100
2024
Q1
$1.02M Buy
3,596
+29
+0.8% +$8.49K 0.16% 104
2023
Q4
$1.03M Buy
3,567
+480
+16% +$131K 0.19% 95
2023
Q3
$830K Sell
3,087
-129
-4% -$32.2K 0.19% 90
2023
Q2
$714K Buy
3,216
+120
+4% +$27.8K 0.17% 101
2023
Q1
$748K Buy
3,096
+294
+10% +$72.2K 0.2% 89
2022
Q4
$736K Buy
2,802
+120
+4% +$32.2K 0.21% 84
2022
Q3
$604K Sell
2,682
-21
-0.8% -$5.09K 0.19% 88
2022
Q2
$657K Sell
2,703
-14
-0.5% -$3.43K 0.2% 86
2022
Q1
$657K Sell
2,717
-326
-11% -$74.9K 0.18% 94
2021
Q4
$684K Buy
3,043
+907
+42% +$191K 0.17% 94
2021
Q3
$455K Buy
2,136
+76
+4% +$17.5K 0.13% 109
2021
Q2
$502K Sell
2,060
-181
-8% -$44.5K 0.15% 106
2021
Q1
$558K Sell
2,241
-123
-5% -$29.3K 0.17% 87
2020
Q4
$544K Buy
2,364
+93
+4% +$21.4K 0.17% 87
2020
Q3
$577K Buy
2,271
+1
+0% +$248 0.2% 75
2020
Q2
$536K Buy
2,270
+257
+13% +$58.6K 0.18% 86
2020
Q1
$408K Buy
2,013
+141
+8% +$30.8K 0.15% 91
2019
Q4
$451K Sell
1,872
-11
-0.6% -$2.42K 0.13% 116
2019
Q3
$364K Buy
1,883
+47
+3% +$9.02K 0.12% 129
2019
Q2
$338K Sell
1,836
-66
-3% -$11.8K 0.11% 141
2019
Q1
$361K Sell
1,902
-171
-8% -$32.7K 0.12% 132
2018
Q4
$403K Buy
2,073
+232
+13% +$45.3K 0.14% 105
2018
Q3
$382K Buy
1,841
+193
+12% +$38K 0.13% 128
2018
Q2
$305K Sell
1,648
-3
-0.2% -$531 0.11% 141
2018
Q1
$281K Sell
1,651
-223
-12% -$40.9K 0.11% 145
2017
Q4
$326K Buy
1,874
+247
+15% +$43.7K 0.12% 132
2017
Q3
$303K Hold
1,627
0.12% 129
2017
Q2
$280K Buy
1,627
+97
+6% +$15.8K 0.12% 128
2017
Q1
$251K Sell
1,530
-12
-0.8% -$1.99K 0.11% 130
2016
Q4
$225K Buy
1,542
+72
+5% +$10.8K 0.1% 145
2016
Q3
$245K Buy
1,470
+7
+0.5% +$1.18K 0.11% 141
2016
Q2
$223K Buy
1,463
+6
+0.4% +$933 0.11% 139
2016
Q1
$218K Buy
1,457
+121
+9% +$18K 0.11% 135
2015
Q4
$217K Sell
1,336
-1
-0.1% -$157 0.11% 135
2015
Q3
$185K Sell
1,337
-1,271
-49% -$200K 0.11% 138
2015
Q2
$400K Buy
2,608
+361
+16% +$57.8K 0.21% 93
2015
Q1
$359K Sell
2,247
-61
-3% -$9.61K 0.19% 111
2014
Q4
$368K Sell
2,308
-11
-0.5% -$1.71K 0.21% 104
2014
Q3
$326K Buy
+2,319
New +$303K 0.2% 116

Other funds holding AMGN

Parkside Financial Bank & Trust's AMGN Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Amgen (AMGN) stake by 0.18% in Q1 2026, selling an estimated $2.5K and leaving 3,990 shares worth $1.4M. The position accounts for 0.11% of the portfolio, ranked #125.

Parkside Financial Bank & Trust first reported a position in AMGN in Q3 2014 and has held it in 47 quarters since. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Parkside Financial Bank & Trust held 3,990 shares of Amgen worth $1.4M as of Q1 2026.
  • Parkside Financial Bank & Trust sold 7 Amgen shares in Q1 2026, an estimated $2.5K.
  • Amgen made up 0.11% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #125 holding.
  • Parkside Financial Bank & Trust first reported a position in Amgen in Q3 2014 and has held it in 47 quarters since.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.